Sectoral Asset Management as of Sept. 30, 2017
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 62 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 4.7 | $36M | 2.4M | 15.08 | |
| Pfizer (PFE) | 4.4 | $34M | 958k | 35.70 | |
| Novartis (NVS) | 4.2 | $33M | 384k | 85.85 | |
| ACADIA Pharmaceuticals (ACAD) | 4.0 | $31M | 822k | 37.67 | |
| Johnson & Johnson (JNJ) | 3.9 | $31M | 235k | 130.01 | |
| Portola Pharmaceuticals | 3.5 | $27M | 506k | 54.03 | |
| Teladoc (TDOC) | 3.1 | $24M | 733k | 33.15 | |
| Acceleron Pharma | 2.9 | $23M | 605k | 37.32 | |
| Loxo Oncology | 2.9 | $23M | 245k | 92.12 | |
| BioMarin Pharmaceutical (BMRN) | 2.9 | $22M | 238k | 93.07 | |
| Medtronic (MDT) | 2.8 | $22M | 281k | 77.77 | |
| Abiomed | 2.8 | $22M | 129k | 168.60 | |
| La Jolla Pharmaceuticl Com Par | 2.7 | $21M | 602k | 34.78 | |
| Merck & Co (MRK) | 2.7 | $21M | 325k | 64.03 | |
| Clovis Oncology | 2.7 | $21M | 252k | 82.40 | |
| Tesaro | 2.5 | $19M | 150k | 129.10 | |
| UnitedHealth (UNH) | 2.5 | $19M | 98k | 195.85 | |
| Gilead Sciences (GILD) | 2.5 | $19M | 235k | 81.02 | |
| K2m Group Holdings | 2.5 | $19M | 897k | 21.21 | |
| Celgene Corporation | 2.4 | $19M | 129k | 145.82 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.4 | $18M | 1.7M | 10.49 | |
| Aerie Pharmaceuticals | 2.3 | $18M | 373k | 48.60 | |
| Global Blood Therapeutics In | 2.1 | $17M | 534k | 31.05 | |
| Acadia Healthcare (ACHC) | 2.0 | $16M | 330k | 47.76 | |
| Molina Healthcare (MOH) | 1.9 | $15M | 220k | 68.76 | |
| Regeneron Pharmaceuticals (REGN) | 1.9 | $15M | 33k | 447.12 | |
| Edwards Lifesciences (EW) | 1.9 | $15M | 133k | 109.31 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $14M | 233k | 61.28 | |
| Prothena (PRTA) | 1.6 | $13M | 196k | 64.77 | |
| Evolent Health (EVH) | 1.5 | $12M | 653k | 17.80 | |
| Spark Therapeutics | 1.3 | $10M | 117k | 89.16 | |
| Wright Medical Group Nv | 1.2 | $9.7M | 374k | 25.87 | |
| Irhythm Technologies (IRTC) | 1.2 | $9.6M | 185k | 51.88 | |
| CIGNA Corporation | 1.1 | $8.5M | 46k | 186.93 | |
| NuVasive | 0.9 | $7.3M | 132k | 55.46 | |
| Integra LifeSciences Holdings (IART) | 0.9 | $7.1M | 141k | 50.48 | |
| Zai Lab (ZLAB) | 0.9 | $7.2M | 266k | 27.00 | |
| Momenta Pharmaceuticals | 0.9 | $6.9M | 373k | 18.50 | |
| Masimo Corporation (MASI) | 0.8 | $6.3M | 73k | 86.57 | |
| Neuroderm Ltd F | 0.7 | $5.7M | 148k | 38.90 | |
| EXACT Sciences Corporation (EXAS) | 0.7 | $5.5M | 118k | 47.12 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.7 | $5.2M | 34k | 152.03 | |
| Envision Healthcare | 0.7 | $5.1M | 114k | 44.95 | |
| Ra Pharmaceuticals | 0.5 | $4.1M | 278k | 14.60 | |
| Incyte Corporation (INCY) | 0.5 | $3.9M | 34k | 116.73 | |
| Ptc Therapeutics I (PTCT) | 0.4 | $3.4M | 171k | 20.01 | |
| Albireo Pharma | 0.4 | $3.3M | 158k | 20.95 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $3.2M | 48k | 66.76 | |
| Intec Pharma | 0.4 | $3.2M | 355k | 8.95 | |
| Sarepta Therapeutics (SRPT) | 0.4 | $3.1M | 69k | 45.36 | |
| NxStage Medical | 0.3 | $2.7M | 99k | 27.60 | |
| Accuray Incorporated (ARAY) | 0.3 | $2.8M | 688k | 4.00 | |
| Dbv Technologies S A (DBVT) | 0.3 | $2.2M | 53k | 42.44 | |
| Spring Bk Pharmaceuticals In | 0.3 | $2.1M | 123k | 16.84 | |
| Insmed (INSM) | 0.2 | $1.9M | 62k | 31.20 | |
| Illumina (ILMN) | 0.2 | $1.9M | 9.4k | 199.25 | |
| Obseva Sa | 0.2 | $1.7M | 213k | 8.14 | |
| Dr. Reddy's Laboratories (RDY) | 0.2 | $1.6M | 46k | 35.68 | |
| Trillium Therapeutics, Inc. Cmn | 0.2 | $1.2M | 234k | 5.15 | |
| Tg Therapeutics (TGTX) | 0.1 | $1.2M | 100k | 11.85 | |
| Clementia | 0.1 | $512k | 30k | 16.89 | |
| Sierra Oncology | 0.0 | $313k | 202k | 1.55 |
